Previous Issue - Issue 45
Issue 45 | 2021
- Foreword
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Information Technology
- Advertorials Go to Digital Magazine
Issue 45
PREVIOUS ISSUE
Strategy
MODELLING SUCCESS
What is a business model, and how can you build one?
As companies from Roche to Merck demonstrate successful adaptation begins with a shared vision of the future business model But therein lies the problem What is a business model Despite it being peppered over every meeting and filling the media there is no agreement amongst either academics or executives about the definition of this ubiquitous term
How Risk-based Approaches to Computer System Validation Support Cost-Effective Compliance and Improved Patient Safety
At the heart of almost all life science and pharmaceutical industry operations are digital information and document handling systems From the earliest clinical phases to the last postapproval study the data and technical documentation these systems manage are essential to the safe effective creation of medicines and therapeutics for all patients
Research & Development
Quaternary ammonium compounds (Quats) against Viruses
Quaternary ammonium compounds Quats such as Benzalkonium Chloride are wellknown membraneactive agents interacting with the cytoplasmic membrane of bacteria and the plasma membrane of yeast
Dissemination of SARS-CoV-2 and the Pathogenesis of COVID-19
Something wicked this way comes
An inverse relationship between aerosolisation of mould spores and incidence of seasonal influenzalike illnesses ILI including COVID has been demonstrated in Chicago
Manufacturing
Catering to an Expanding Parenteral Drug Market
How drug manufacturers can adapt packaging for injectables to meet evolving patient needs
Prepandemic trends can feel like a distant memory but prior to the onset of the Coronavirus demand for parenteral drugs was already on the rise In alone there were nearly parenteral drugs in the pipeline
Information Technology
Transformation through Digital Innovation
The COVID pandemic has accelerated change like never before and digital transformation is reshaping business models across industries including pharmaceuticals Adaptability to changing market conditions has pushed companies to evaluate and renew their business models around sustainability
HEALTHCARE AND PHARMA NEED TO BUILD IMMUNITY AGAINST CYBER THREATS
In August ransomware operators targeted the health department of the Italian region of Lazio and disabled its COVID vaccination booking system disrupting the scheduling of new vaccination appointments for days
